Recombinant Vaccine

This page contains recent news articles, when available, and an overview of Recombinant Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on Recombinant Vaccine

[an error occurred while processing this directive]

News: Recombinant Vaccine

Medicago signs second licensing agreement with Fortune 100 Company  -  Feb 7, 2008
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Camote beats dengue fever  -  Jan 28, 2008
Sun.Star,Research is also being conducted to develop second-generation recombinant vaccine viruses. "Therefore, an effective dengue vaccine for public use will not

The OIE expands its action in biotechnologies in anticipation of ...  -  Jan 31, 2008
OIE (press release),Aujeszky's disease (pseudorabies) is also under control in many parts of the Americas and Europe mainly thanks to a recombinant vaccine.

Aeras and Crucell Announce Start of a Tuberculosis Vaccine ...  -  Dec 20, 2007
FOX NewsThe AdVac(R) technology is specifically designed to manage the problem of pre-existing immunity in humans against the most commonly used recombinant vaccine

Merck Vaccine Recall Due To Equipment Contamination  -  Dec 12, 2007
eMaxHealth.com,COMVAX [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine] is indicated for vaccination against invasive

Merckâ€™s Vaccine Gardasilâ„¢ Will Be Best-Selling 2006-Approved ...  -  Dec 22, 2007
PR-USA.net (press release),Gardasil/ Silgard (human papillomavirus vaccine) is a recombinant vaccine indicated for the prevention of cervical cancer caused by human papillomavirus

GE Healthcare, Novavax To Develop Pandemic Influenza Product  -  Dec 10, 2007
CNNMoney.comNovavax , a biopharmaceutical delivery company, said the goal is for a recombinant vaccine to be produced within 12 weeks of identification of a pandemic

Medicago signs collaboration and licensing agreement for ...  -  Dec 19, 2007
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

CDC's Answers On Merck's Hib Vaccine Recall  -  Dec 12, 2007
eMaxHealth.com,Protein Conjugate)] and two lots of COMVAXÂ® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine].

Aeras and Crucell Announce Start of a  -  Dec 20, 2007
Ad-Hoc-News (Pressemitteilung),The AdVacÂ® technology isspecifically designed to manage the problem of pre-existing immunityin humans against the most commonly used recombinant vaccine

GE Healthcare and Novavax Establish Collaboration To Develop and ...  -  Dec 10, 2007
CNNMoney.comThe goal is that any required recombinant vaccine could be produced in cell culture within 12 weeks of identification of a pandemic strain, without using

Merck Recalls Hib Vaccine  -  Dec 15, 2007
eMaxHealth.com,...(Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine]. The affected doses were distributed throughout the US starting in April 2007.

STALLERGENES and Protein' eXpert Enter Into a Partnership for ...  -  Dec 13, 2007
PR Newswire (press release),...allows ensuring a seamless transfer from early research to clinical production stages for therapeutic protein and recombinant vaccine projects.

The Early Edge: UBS, Blackstone, Rio Tinto, Novavax, and MGI Pharma  -  Dec 10, 2007
Schaeffers Research,The goal of the new collaborative is to produce a recombinant vaccine within 12 weeks of a new pandemic strain being identified, without having to use eggs

Medicago announces technological milestone with production of self ...  -  Oct 18, 2007
CNW Telbec (CommuniquÃ©s de presse),..."Our transient expression system which produces recombinant vaccine antigens in the cells of non-transgenic plants has demonstrated its efficiency and

Merck to Donate Three Million Doses of Gardasil  -  Oct 16, 2007
Scoop.co.nz,11, 16, 18) Recombinant Vaccine], the cervical cancer vaccine, for use in demonstration projects in low income nations throughout the world.

Serum Institute to tap US, European markets  -  Sep 28, 2007
Sify,Pune: Vaccine-maker Serum Institute of India Ltd will invest Rs 800-1000 crore over the next few years in developing new products and setting up plants that

Notice to Readers: FDA Approval of an Alternate Dosing Schedule ...  -  Oct 11, 2007
Trading Markets (press release),Twinrix[Note (R)] (hepatitis A inactivated & hepatitis B [recombinant] vaccine). Available at http://www.fda.gov/cber/label/hahbgsk032807lb.pdf.

GSK Asks WHO for Cervarix Prequalification  -  Oct 11, 2007
FDA news (subscription),The product has been launched and is priced in the UK the same as Merckâ€™s Gardasil (quadrivalent HPV types 6, 11, 16, 18 recombinant vaccine).

Gardasil Adverse Events Include Deaths, Seizures, Judicial Watch Says  -  Oct 10, 2007
FDA news (subscription),1824 reports of adverse reactions to Gardasil (quadrivalent human papillomavirus [Types 6, 11, 16, 18] recombinant vaccine), including eight deaths.

HPV vaccine recommended for women through age 26  -  Sep 27, 2007
The Daily Toreador (subscription),Unlike many vaccines, Gardasil is a recombinant vaccine, which means it does not contain any live forms of the virus. According to the CDC Web site,

Gardasil(R) may offer additional protection against 10 extra ...  -  Oct 5, 2007
Canada NewsWire (press release),11, 16, 18) Recombinant Vaccine) has been shown to be up to 100 per cent effective at preventing cervical cancer caused by HPV types 16 and 18,

Merck's Gardasil and Januvia Receive Prix Galien USA Top Honors  -  Sep 27, 2007
PharmaLive.com (press release),WHITEHOUSE STATION, NJ--(BUSINESS WIRE)--Sep 27, 2007 - GARDASIL(R) (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine),

Shantha Biotech chief laments official apathy  -  Aug 19, 2007
Siasat Daily,In fact, Shantha Biotechnics Ltd combined Hep-B with DPT and released a recombinant vaccine. The Governments were not encouraging local entrepreneurs,

Meridian to begin virus vaccine trials  -  Aug 28, 2007
Bizjournals.com,Meridian was awarded a contract in 2003 to develop the recombinant vaccine, based on technology invented by an NIH physician. The company, in 2005,

Medicago announces second quarter results  -  Aug 29, 2007
Canada NewsWire (press release),To face pandemic and seasonal vaccine supply challenges, Medicago has developed a proprietary transient expression system which produces recombinant vaccine

Developing of CubaÃ¢â‚¬â„¢s biotechnology is up and going  -  Aug 28, 2007
Cuba Headlines,Amidst the medications Cuba produces are the Anti-hepatitis B recombinant vaccine, a leading product accepted in the World Health Organization campaigns

Merck Frosst responds to Maclean's  -  Aug 20, 2007
Canada NewsWire (press release),...(6) Comprehensive clinical research program Gardasil(R) (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine) clinical data is

Hepatitis B Vaccine Protection May Not Be Long-Lasting  -  Aug 6, 2007
MedPage Today,Another possible explanation is the slight differences in the antigen used for the serum-derived vaccine and the antigen used in the recombinant vaccine.

FDA Reviews GARDASIL Vaccine  -  Jun 24, 2007
Vaccine Rx (press release),GARDASUL Â® is a recombinant vaccine that protects against the main types of HPV (types 16 and 18) that lead to vaginal and vulvar cancer as well as genital

Merck Provides Update on Status of Supplemental Biologics License  -  Jun 21, 2007
WebWire (press release),...review a supplemental Biologics License Application (sBLA) for GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine].

Asian Diplomats Praise Cuban Advances in Biotechnology  -  Jun 29, 2007
Cuba News,...including the Heberbiovac or recombinant vaccine against Hepatitis B, thanks to which only one person has died in Cuba due to this disease since 2006.

Cancer biotherapy market set to boom  -  Jun 11, 2007
BiopharmaReporter.com,Merck's Gardasil (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine) and Dacogen (decitabine), which were recently approved.

FDA Finalizes Guidances For Pandemic And Seasonal Influenza Vaccines  -  05 Jun 2007
Medical News Today (press release),...scientific advances, such as cell-culture derived and recombinant vaccine technologies, into new medical products with shorter approval timeframes.

FDA issues guidance on flu vaccine development  -  Jun 4, 2007
CIDRAP,...to translate scientific advances, such as cell cultureâ€“derived and recombinant vaccine technologies, into approved medical products, the agency said.

FDA Finalizes Guidance for Pandemic and Seasonal Influenza Vaccines  -  Jun 1, 2007
DG News...scientific advances, such as cell-culture derived and recombinant vaccine technologies, into new medical products with shorter approval timeframes.

Whatâ€™s Behind the HPV Vaccine Hype?  -  May 16, 2007
Synapse,GardasilÂ® is a quadrivalent Human Papillomavirus (HPV Types 6, 11, 16, 18) recombinant vaccine, manufactured by Merck. The vaccine was FDA approved in June

UQ Research Heralds Vaccine Technology Breakthrough  -  May 12, 2007
Medical News Today (press release),The research group has developed a "recombinant" vaccine using the existing Hepatitis B vaccine to carry the RSV peptides.

Retrospective Observational Study Shows Combination Vaccines May ...  -  May 28, 2007
Medical News Today (press release),Vaccine Combined] or ComvaxÂ® [Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine] had higher immunization

New Vaccine Technology Should Protect Children From Common ...  -  May 8, 2007
Science Daily (press release)The research group has developed a "recombinant" vaccine using the existing Hepatitis B vaccine to carry the RSV peptides. "Hepatitis B surface antigen

NEJM publishes new data on GARDASIL, Merck's Cervical Cancer Vaccine  -  May 14, 2007
SpiritIndia,...from two Phase III studies of Merck's cervical cancer vaccine, GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine].

FDA Issues Final Guidelines Regarding Flu Vaccine  -  May 31, 2007
DentalPlans.com,...of scientific advancements such as cell-culture derived and recombinant vaccine technologies to develop new medicines that can be approved more quickly.

Data Published in The Lancet Show GARDASIL(R) was 100 Percent ...  -  May 18, 2007
PipelineReview.com (press release),11, 16, 18) Recombinant Vaccine] was 100 percent effective in preventing high-grade vulvar and vaginal dysplasias caused by HPV types 16 and 18,

Crucell, AERAS and SATVI Announce Start of Tuberculosis Vaccine ...  -  May 12, 2007
PipelineReview.com (press release),The AdVac(R) technology is specifically designed to manage the problem of pre-existing immunity in humans against the most commonly used recombinant vaccine

/REPEAT/ - The Lancet publishes data showing Gardasil(TM) protects ...  -  May 18, 2007
CNW Telbec (CommuniquÃ©s de presse),11, 16, 18) Recombinant Vaccine) provided 100 per cent protection against vulvar and vaginal disease caused by the four vaccine HPV types among women

Market Report -- In Play (MRK)  -  May 17, 2007
MSN MoneyGARDASIL (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine) was 100% effective in preventing high-grade vulvar and vaginal

Vaccination Prior to HPV Infection is Key to Protection  -  May 14, 2007
Cancer Consultants (press release),Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) has high efficacy when given to girls and women who are not already infected with HPV.

New England Journal of Medicine Publishes New Data on GARDASIL ...  -  May 10, 2007
WebWire (press release),...from two Phase III studies of Merckâ€™s cervical cancer vaccine, GARDASIL [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine].

Immunogenic Recombinant Flu Vaccine Incubated in Insect Cells  -  Apr 10, 2007
MedPage Today,Point out that the recombinant vaccine was safe and produced powerful immune responses. The vaccine, which includes recombinant proteins from three strains

Scientists Develop Safe Plant-Based Smallpox Vaccine  -  Apr 9, 2007
Voice of America..."The availability of a safe, recombinant vaccine would be a big step forward in implementing what people believe would be a prudent policy of vaccinating a

Accelerated Dosing Schedule Approved for TwinrixÂ® Vaccine for ...  -  Apr 3, 2007
EndoNurse,...that the US Food and Drug Administration (FDA) has approved TwinrixÂ® [hepatitis A Vaccine (Inactivated) and hepatitis B (Recombinant) Vaccine],

Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA ...  -  Apr 18, 2007
PipelineReview.com (press release),11, 16, 18) Recombinant Vaccine] to the US Food and Drug Administration (FDA) to update the labeling for GARDASIL, the cervical cancer vaccine.

Accelerated Dosing Schedule Approved for Twinrix  -  Apr 3, 2007
Facts and Comparisons,The FDA has approved GlaxoSmithKlineâ€™s Twinrix (hepatitis A vaccine [inactivated] and hepatitis B [recombinant] vaccine) for an accelerated dosing schedule

CDC Finalizes Advisory Panel Recommendations for GARDASIL ...  -  Apr 15, 2007
eMaxHealth.com,...(ACIP) for the use of GARDASILÂ® [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] in girls and women ages 11 through 26.

CDC Guidelines Recommend GardasilÂ®  -  Apr 16, 2007
Cancer Consultants (press release),...adopted recommendations for Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) use in girls and women age 11 to 26.

FDA Licenses New Vaccine for Prevention of Cervical Cancer  -  Apr 5, 2007
RushPRnews.com (press release),Gardasil is a recombinant vaccine (contains no live virus) that is given as three injections over a six-month period. Immunization with Gardasil is expected

Contentious vaccine?  -  Mar 31, 2007
Malaysia Star,The Quadrivalent Human Papillomavirus Recombinant Vaccine protects against four of the most prevalent strains of HPV that can lead to cervical cancer

GlaxoSmithKline says FDA approves accelerated dosing schedule for ...  -  Apr 2, 2007
Forbes,US Food and Drug Administration has approved Twinrix hepatitis A vaccine (inactivated) and hepatitis B (recombinant) vaccine for an accelerated dosing

FDA Approves Accelerated Dosing Schedule for GlaxoSmithKline's ...  -  Apr 2, 2007
PR Newswire (press release),...today that the US Food and Drug Administration (FDA) has approved Twinrix(R) [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine],

GardasilÂ® Vaccination Guidelines Adopted by CDC  -  Apr 13, 2007
Cancer Consultants (press release),...(ACIP) for Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) use in girls and women 11 to 26 years of age.[1]

Hepatitis-E outbreak in Sopur, 1 dies  -  Apr 20, 2007
GreaterKashmir.com (press release),...hepatitis and fulminant hepatic failure. A recombinant vaccine for hepatitis E has passed through phase I study and phase II and III trials are underway.â€?

Search the web for more resources on Recombinant Vaccine

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.